Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases
Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry...
Day: January 22, 2025
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
Sale of GOLIKE® Rights Outside the U.S. to NutrisensRelief to Focus on R&D of Pipeline Assets and Licensing for Commercialized...
Hemostemix Announces Grant of Stock Options
Calgary, Alberta--(Newsfile Corp. - January 22, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...